OTUD3-mediated deubiquitination licenses TEX264 to orchestrate ER-phagy for KDM5B degradation in teniposide lung cancer therapy.
第一作者:
Ning,Han
第一单位:
Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Donghu Avenue No.185, Wuhan, 430072, China; Shiyan Key Laboratory of Natural Medicine Nanoformulation Research, Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences, Hubei University of Medicine, Renmin Road No. 30, Shiyan, Hubei, 442000, China.
作者:
医学主题词
肺肿瘤(Lung Neoplasms);人类(Humans);动物(Animals);泛素化(Ubiquitination);含Jumonji结构域组蛋白脱甲基酶类(Jumonji Domain-Containing Histone Demethylases);小鼠(Mice);内质网(Endoplasmic Reticulum);阻遏蛋白质类(Repressor Proteins);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);抗肿瘤药(Antineoplastic Agents);核蛋白质类(Nuclear Proteins)
DOI
10.1016/j.ejphar.2026.178685
PMID
41763483
发布时间
2026-03-17
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



